MASTER DEVELOPER AWARDS NEARLY HALF MILLION TO CITY

RXR, a leading real estate owner, operator and the master developer for Downtown New Rochelle, recently announced it is awarding $100,000 to Boys & Girls Club of New Rochelle (BGCNR). This contribution marks one year since RXR announced a $500,000 grant program dedicated to the health, well-being and safety of New Rochelle's children and families. Since its launch last year, RXR has committed more than $480,000 to various youth programming and educational initiatives.

The new $100,000 grant will support Boys & Girls Club of New Rochelle’s Mascaro and Remington clubhouses, expanding on the services and programs they can provide in two of New Rochelle’s most underserved neighborhoods. Grant money will directly support improvements for both clubhouses, including the renovation of rooms, purchasing of new materials, operational costs and general building needs. RXR’s continued investment in Boys & Girls Club of New Rochelle is critical in supporting these communities.

Since being selected as Master Developer of New Rochelle in 2015, RXR has created more than 3.3 million square feet of commercial and retail space and 5,500 new residential units.

"Since RXR was selected as the downtown master developer by the city of Rochelle, we’re proud to have created thousands of new residential units, hundreds of new jobs, and to leverage this new development to support New Rochellians," said Joseph Graziose Jr., executive vice president, development services at RXR.

“We are incredibly grateful to RXR for their generous support and ongoing commitment to Boys & Girls Club of New Rochelle. Their latest investment in our Mascaro and Remington clubhouses is vital in our mission to encourage and empower youth in need in New Rochelle,” said Becky Mazzanobile, CEO, Boys & Girls Club of New Rochelle. “…The work done at our clubhouses has a direct impact on the lives of New Rochelle’s youth and, more broadly, the city of New Rochelle – over 80% of our members do service in the community – and we strive

Chair Of Medicine Appointed

to ensure that each child achieves academic success, lives a healthy lifestyle and displays civic responsibility. We’re thankful to RXR for its unwavering support.”

Launched in the spring of 2022, the $500,000 youth programming grant program follows RXR’s previous contribution of more than $1 million in Covid relief funding to various nonprofit organizations in New Rochelle and the surrounding region over the past two years. Grants up to $25,000 were awarded as supplemental funding to existing programs, while applicants for grants above $25,000 were encouraged to partner with other nonprofit organizations in New Rochelle to either establish or expand innovative programming that targets a specific need or population.

When New Rochelle became the nation’s early Covid epicenter in 2020, RXR quickly established a Covid Relief Fund with $1 million in seed funding to help the city’s residents, businesses and nonprofits. To date, the fund has disbursed over $1 million in grants, including $486,000 to Rebound New Rochelle – a small-business relief program, providing $5,000 - $10,000 in grants to women/minority business owners, bilingual business liaison support and strategic consulting services.

RXR is an innovative investor, developer and place-maker committed to applying a customer and community-centered approach to building properties, services and products that create enduring value for all stakeholders. Headquartered in New York with a national platform strategy, RXR is a 500+ person, vertically integrated operating and development company with expertise in a wide array of value creation activities, including ground-up real estate, infrastructure and industrial development. The RXR platform manages 91 commercial real estate properties and investments with an aggregate gross asset value of approximately $20 billion, comprising approximately 30.0 million square feet of commercial properties, a multifamily residential portfolio of approximately 8,800 units under operation or development, and control of development rights for an additional approximately 3,500 multifamily and for sale units as of March 31.

After an extensive national search by a committee with broad representation, a clear consensus emerged that New York Medical College’s (NYMC) chair of medicine Neil W. Schluger, M.D., was by far the best candidate for dean of its School of Medicine. An internationally recognized pulmonologist, Schluger has accepted the position. He served as the Barbara and William Rosenthal chair of the Department of Medicine and professor of medicine at NYMC and director of medicine at Westchester Medical Center since 2020. He assumes his new duties on Aug. 15. Schluger succeeds Jerry L. Nadler, M.D., who stepped down as dean in January 2023 following the death of his beloved wife and supporter of the School of Medicine (SOM), Mary Latona Nadler.

Since joining NYMC, Schluger has distinguished himself as a clinician, researcher and educator, leading a department of more than 425 faculty members and teaching more than 800 medical students and residents. In 2021, he took on the additional role of associate dean for clinical and translational research for the SOM.

Previously, Schluger served as chief of the division of pulmonary, allergy and critical care medicine at Columbia University Irving Medical Center; professor of medicine, epidemiology and environmental health sciences; director of the Popula- tion and Global Health Track for the Scholars Projects Program; and co-director of the programs in Education and Global and Population Health for the Vagelos College of Physicians and Surgeons at Columbia University. He is a founder of the East Africa Training Initiative in Pulmonary Medicine (EATI). The two-year fellowship training program in pulmonary and critical care medicine, which recently marked its 10th anniversary, is the first training program of its kind in Ethiopia and the broader East African region. Before the launch of EATI, Ethiopia had only one pulmonologist for its 110 million people. EATI has, thus far, graduated 18 specialists, including two pediatric pulmonologists and two physicians from Rwanda and Tanzania, who have assumed leadership roles at hospitals across East Africa.

Schluger has been a principal investigator in the Tuberculosis Trials Consortium, an international collaboration sponsored by the U.S. Centers for Disease Control and Prevention (CDC) for 25 years and was the chair of the consortium from 2000-2016. He has been an author or editor of several editions of “The Tobacco Atlas,” the definitive work describing the extent and consequences of the global epidemic of tobacco use, published by Vital Strategies and the American Cancer Society. He is also the author of more than 200 articles, chapters and books, past chair of the American Lung Association of New York, past chief scientific officer of the World Lung Foundation and a voice in the media on re-infection, long-term symptoms and the use of hydroxycholoroquine for treating Covid-19.

Board-certified in pulmonary disease and internal medicine, Schluger is a graduate of Harvard College, earned his medical degree from the University of Pennsylvania, completed a residency in internal medicine and served as chief resident at St. Luke’s Hospital in New York. He later completed a three-year pulmonary and critical care medicine fellowship at The New York Hospital/Cornell Medical Center.

HEALTH-CARE COMPANY PUBLISHES INAUGURAL SUSTAINABILITY REPORT

Prestige Consumer Healthcare Inc. in Tarrytown announced the release of its inaugural Environmental, Social and Corporate Governance (ESG) Sustainability Report, which highlights its attributes and the steps it has taken to establish baselines to measure the company’s sustainability strategy. The company’s ESG framework is centered on three pillars – supporting an inclusive workforce, responsible corporate citizenship and producing sustainably.

“We are a company dedicated to delivering our consumers a safe and efficacious consumer health-care product portfolio that is supported by our company’s Environmental, Social and Corporate Governance framework,” said Ron Lombardi, CEO. “That mission is the guiding force behind our operations and we’re proud to formally share with all of our stakeholders how it has helped to inform our ESG strategy. We have internally aligned ourselves to identify where opportunities exist in terms of addressing key ESG issues and have anchored ESG into all facets of our business. By leveraging our guiding principles, we pledge as a company to address each ESG topic to ensure we continually help our consumers care for themselves and their loved ones for generations to come,” he said.

A leading consumer health-care products company with sales throughout the U.S. and Canada, Australia, and in certain other international markets Prestige’s portfolio of brands is diverse and iconic.

To read the full Prestige Consumer Healthcare 2023 Sustainability Report and learn more about the Company’s ESG journey, visit esg.prestigeconsumerhealthcare.com

Seasoned Company Builder To Chair Board Of Biotech Company

AI Therapeutics Inc., a clinical-stage biopharmaceutical company in Guilford, Connecticut, developing novel therapeutics for rare diseases, recently announced the appointment of David Scheer as chairman of its Board of Directors.

Scheer brings decades of experience to AI Therapeutics, having founded, built and advised multiple biotechnology companies, including Achillion, Viropharma, OraPharma and the original Esperion Therapeutics, which were cumulatively acquired for nearly $7 billion. Since 1981, Scheer has provided corporate strategic and transactional advisory services to the life sciences industry as founder and president of Scheer & Company and has supported several companies through highly successful IPOs.

Currently, Scheer is chair of the boards of BiologicsMD Inc., Adela Inc., and Refactor Health. He also, among the many global initiatives he’s involved with, serves as a member of the Board of Directors of BioCT and the Bioscience Innovation Advisory Committee, which oversees investments made by the $200 million

Team Promotions At Architecture Firm

KG+D Architects PC in Mount Kisco has named Sarah Davis, AIA, LEED AP and Lisa DelPercio, LEED AP as associates of the firm. Davis has successfully managed complex projects and provided services to KG+D clients, including the Croton Harmon Union Free School District and Valhalla Union Free School District. As the business manager, DelPercio has contributed to the management of the design practice by regularly interfacing with firm clients and managing responsibilities in business, finance, administration, human resources and operations.

Davis of Rye, New York, holds a Master of Architecture degree from Washington University in St. Louis and a Bachelor of Arts degree from Smith College.

DelPercio, LEED AP of Dutchess County joined KG+D in 2021 as the business manager. She brings decades of industry experience with a unique vari- ety of skills necessary to help manage a design practice. She studied art history at Queens College and interior design at the New York School of Interior Design.

“Their promotions reflect our firm’s commitment to building a strong and dynamic team, as well as our confidence in their continued ability to deliver the highest quality of service to our clients,” said Russell A. Davidson, firm president, joined by Erik A. Kaeyer, vice president; Walter P. Hauser, vice president; Sarah Dirsa, principal; Brian Mangan, principal; Travis Schnell, principal; and Susan Davidson, associate principal.

KG+D aspires to be the first choice for individuals and communities who want to work together to improve the built environment through engaging, sustainable and inspiring design. Founded as KG+D Architects in 1994, the firm has built upon a well-established legacy of its predecessor firms for more than 85 years.

Connecticut Bioscience

Scheer holds an A.B. degree cum laude in biochemical sciences from Harvard College and an M.S. degree in cell, molecular and developmental biology from Yale University.

“…David (Scheer) has a stellar track record of creating and maximizing value in the biotechnology industry. We look forward to his contributions to AI Therapeutics as the company enters an exciting phase in its development,” said Dr. Jonathan Rothberg, founder of AI Therapeutics, serial entrepreneur and recipient of the National Medal of Technology and Innovation for inventing high-speed “Next-Gen” DNA sequencing.

“…We look forward to working with David as we further our mission of delivering life-saving medicines to patients with rare diseases,” said Dr. Brigette Roberts, CEO of AI Therapeutics. “In addition to welcoming David, we would also like to thank Dr. Rothberg for his many contributions to AI Therapeutics as founder and chairman. Dr. Rothberg is a true visionary, and we are grateful for his continued involvement as a director of the company.”

AMERICANS WITH DISABILITIES ACT’S 33RD ANNIVERSARY

Lt. Gov. Antonio Delgado will be the keynote speaker at a special event commemorating the 33rd anniversary of the American with Disabilities Act on July 26 at Crawford Park Pavilion, 122 N. Ridge St. in Rye Brook, from 1 to 3 p.m.

Elected officials, including New York state Senate Majority Leader Andrea Stewart Cousins and New York state Senator Shelley Mayer, Assemblymen

Chris Burdick and Nader Sayegh as well as groups representing people with disabilities will be attending the celebration.

“Before this historic civil rights protection law went into effect in 1990, people with disabilities were severely limited in their access to public and other buildings. Even the simple things that we now take for granted such as sidewalk curb cuts and audible traffic signals were not required. If you can imagine a world where people with physical limitations were barred from participating in even the simplest activities. The ADA opened up a whole new world for people with disabilities,’’ said Maria Samuels, executive director of Westchester Disabled on the Move.

The legislation was signed on July 26, 1990, by the late President George H.W. Bush. It protects many areas of public accommodations and life for people with disabilities.